GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR (2025)
- Authors:
- Autor USP: ULRICH, ALEXANDER HENNING - IQ
- Unidade: IQ
- DOI: 10.1016/j.expneurol.2024.115006
- Subjects: ARTÉRIA CEREBRAL MÉDIA; PROTEÍNAS QUINASES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Experimental Neurology
- ISSN: 0014-4886
- Volume/Número/Paginação/Ano: v. 383, p. 1-13 art. 115006, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CAVALCANTE, Daniel Pereira et al. GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR. Experimental Neurology, v. 383, p. 1-13 art. 115006, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.expneurol.2024.115006. Acesso em: 23 fev. 2026. -
APA
Cavalcante, D. P., Nunes, A. Í. dos S., Silva, E. R. da, Carvalho, G. A. de, Chiareli, R. A., Lima, O. C. O., et al. (2025). GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR. Experimental Neurology, 383, 1-13 art. 115006. doi:10.1016/j.expneurol.2024.115006 -
NLM
Cavalcante DP, Nunes AÍ dos S, Silva ER da, Carvalho GA de, Chiareli RA, Lima OCO, Leoncini GO, Ulrich H, Gomez RS, Pinto MCX. GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR [Internet]. Experimental Neurology. 2025 ; 383 1-13 art. 115006.[citado 2026 fev. 23 ] Available from: https://dx.doi.org/10.1016/j.expneurol.2024.115006 -
Vancouver
Cavalcante DP, Nunes AÍ dos S, Silva ER da, Carvalho GA de, Chiareli RA, Lima OCO, Leoncini GO, Ulrich H, Gomez RS, Pinto MCX. GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR [Internet]. Experimental Neurology. 2025 ; 383 1-13 art. 115006.[citado 2026 fev. 23 ] Available from: https://dx.doi.org/10.1016/j.expneurol.2024.115006 - Aluminum-induced alterations of purinergic signalling in embryonic neural progenitor cells
- Nitric oxide in the differentiation of neural stem cells and its interrelationship with purinergic system
- Spontaneous calcium oscilation are modulated by P2 purinergic receptors and control expression of neurogenesis related transcription factors (Oral communication)
- RNAi-based strategy to study the role of P2X7 receptor in the temporal lobe epilepsy
- Extracellular nucleotides and purinergic signaling as novel underappreciated pro-metastatic chemotactic factors for human lung cancer cells
- Purinergic signaling during Porphyromonas gingivalis infection
- Purinergic signaling in differentation and neural phenotype determination
- Novel roles of highly specific natural inhibitors of the angiotensin-converting enzyme
- Both P2X7-KO and CD73-KO mice display normal hematopoiesis in non-stress mediated steady state conditions
- Cell cycle regulation during neurogenesis in the embryonic and adult brain
Informações sobre o DOI: 10.1016/j.expneurol.2024.115006 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3220800.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
